-
Acadia Healthcare (ACHC) PT Lowered to $28 at RBC Capital as 'Medicaid Volume Weighs on Outlook'
-
RBC Capital on Acadia Healthcare (ACHC): 'New LT Growth Targets Reflect Longer De Novo Ramp'
-
RBC Capital Reiterates Outperform Rating on Acadia Healthcare (ACHC)
-
Acadia Healthcare to Participate in the BofA Securities 2021 Healthcare Conference and the 2021 RBC Capital Markets Global Healthcare Conference
-
Acadia Healthcare to Participate in the UBS Virtual Global Healthcare Conference and the RBC Capital Markets Global Healthcare Virtual Conference
-
Acadia Healthcare (ACHC) PT Lowered to $42 at RBC Capital
-
RBC Capital Discusses Today's Weakness in Acadia (ACHC)
-
Acadia Healthcare to Participate in RBC Capital Markets 2017 Healthcare Conference
-
Acadia Healthcare to Participate in RBC Capital Markets 2016 Healthcare Conference
-
Notable Analyst Rating Changes 6/19: (EAC) (FISV) (EPE) Upgraded; (BMRN) (AIT) (BP) Downgraded
-
Acadia Healthcare Announces Closing of Equity Offering and Underwriters’ Exercise of Option to Purchase Additional Shares
-
Acadia Healthcare (ACHC) Prices 4.5M Common Offering at $66.50/Share
-
Acadia Healthcare Announces Pricing of Offering of 4,500,000 Shares of Common Stock
-
Acadia Healthcare (ACHC) to Offer 4.5M Common Shares
-
Acadia Healthcare Announces Proposed Offering of 4,500,000 Shares of Common Stock
-
Acadia Healthcare (ACHC) Underwriters Exercise Full Overallotment in Recent Offering
-
Acadia Healthcare (ACHC) Announces 9.58M Common Offering
-
Acadia Healthcare (ACHC) Prices 8.33M Share Public Offering at $7.50/Share
-
Acadia (ACHC) Authorizes 8.33M Common Offering

